Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
5 Best CEFs This Month For 8.5% Yield (November 2024)
09:30am, Sunday, 24'th Nov 2024
For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs,
Eli Lilly: Steep Pullback, Still Compelling Here
11:45am, Saturday, 23'rd Nov 2024
LLY's recent sell-off has been unwarranted indeed, since the lowered FY2024 guidance is attributed to the complexities of inventory management and non-cash/ one-time IPR&D charges. Even so, the pullba
Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?
10:00am, Saturday, 23'rd Nov 2024
After flying high during the first half of the year, pharmaceutical giant Eli Lilly (LLY -0.26%) has lost some momentum; the company's shares are down by 11% since June 1. However, the healthcare lead
Potential $5,000 Monthly Income: 10 Investments To Buy And Hold For Next 10 Years
09:00am, Saturday, 23'rd Nov 2024
We present a highly diversified yet simple portfolio of 10 positions, with 9 funds and one individual MLP stock. The portfolio has been designed for retirees and investors planning for retirement, wit
2 Incredible Growth Stocks to Buy With $1,000 Right Now
06:15am, Saturday, 23'rd Nov 2024
2 Incredible Growth Stocks to Buy With $1,000 Right Now
Investing in Pharma Stocks? Check These 3 Things First
09:15am, Friday, 22'nd Nov 2024
Investing in Pharma Stocks? Check These 3 Things First
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
12:47pm, Thursday, 21'st Nov 2024
Eli Lilly and Co. LLY has seen better days. The stock is up 26.04% for the last year but has struggled recently, falling 17.57% over the last month.
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
10:00am, Thursday, 21'st Nov 2024
Shares of Lilly are cratering, but investors may be surprised to learn what's influencing the volatility.
Are Dietary Drug Stocks Eli Lilly and Novo Nordisk Ready To Rise Again?
08:31pm, Wednesday, 20'th Nov 2024
In today's article I will try to answer the question on whether the two premier diet drug companies stocks have finally stopped going down? I will look at two stocks (dietary drug is in parenthesis):
China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
10:11am, Wednesday, 20'th Nov 2024
Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients lose weight while preserving muscle, the biotech said on Wednesday.
The collaboration will accelerate the global development of LAE102, a novel Activin Receptor Type 2 A (ActRII A ) Antagonistic Monoclonal Antibody (mAb) for muscle-preserving weight loss in Obesity LO
Is It Time to Sell Eli Lilly and Pfizer Stocks?
05:48am, Wednesday, 20'th Nov 2024
Is It Time to Sell Eli Lilly and Pfizer Stocks?
Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
05:00am, Wednesday, 20'th Nov 2024
— Lilly to Develop Two Targets Identified and Validated Using Verge Genomics' AI-Enabled, All-in-Human CONVERGE® Platform
Lilly announces changes on board of directors
04:30pm, Tuesday, 19'th Nov 2024
INDIANAPOLIS , Nov. 19, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has elected Jon Moeller as a new member of its board of directors, effective Dec. 1, 2024. In ad
Healthy Returns: Eli Lilly's cholesterol pill impresses in mid-stage trial
04:04pm, Tuesday, 19'th Nov 2024
Eli Lilly's cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.
